A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection
Status:
Completed
Trial end date:
2001-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if infection with Mycobacterium avium complex (MAC)
occurs in other parts of the body before it is found in the blood. This study also evaluates
the relationships between the amount of HIV in the blood, immune system functions, and the
presence of MAC infection.
HIV-positive patients are at risk for MAC infection because their immune systems have been
weakened by HIV. It is hoped that aggressive treatment with anti-HIV drugs may improve their
immune systems enough to prevent against MAC.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)